Next Step for Phase 1 GBR 1342 Studies - Identify the maximum tolerated dose to proceed to Phase 2

Next Step for Phase 1 GBR 1342 Studies - Identify the maximum tolerated dose to proceed to Phase 2

User Photo
ASHReport

2 years
260 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Joshua Richter, MD from John Theurer Cancer Center discusses next step for Phase 1 GBR 1342 studies and identifying the maximum tolerated dose to proceed to Phase 2 at the 2017 American Society of Hematology.
Up Next Autoplay